International Clinical Trial: Early Use of Methylene Blue in Septic Shock

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128808) titled 'Early Use of Methylene Blue in Septic Shock' on July 27.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

Condition: Septic shock

Intervention: Methylene blue group:Combined use of methylene blue

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-08-05

Target Sample Size: Methylene blue group:66;Control Group:66;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=306833

Disclaimer: Curated by HT Syndication....